Author | Jennifer Barrett


FDA OKs New Treatment for Seizures Associated with Dravet Syndrome

June 26, 2020


Officials with the FDA approved fenfluramine (Fintepla, Zogenix) oral solution, CIV for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older.

FDA Clears First Prescription Game-Based Treatment Device for Children With ADHD

June 17, 2020


EndeavorRx (Akili Interactive), a prescription-only game-based device, is indicated for use in children ages 8 to 12 years old with primarily inattentive or combined-type ADHD who have demonstrated an attention issue.

FDA OKs FreeStyle Libre 2 System for Adults and Children With Diabetes

June 15, 2020


Abbott’s FreeStyle Libre 2 is an integrated continuous glucose monitoring system for adults and children ages 4 and older with diabetes.

ADA 2020: FreeStyle Libre System Use Decreases Diabetic Ketoacidosis Rates

June 13, 2020


New findings from a study presented at the ADA’s 80th Scientific Sessions showed a dramatic drop in diabetic ketoacidosis hospitalizations in patients who used the FreeStyle Libre system